
Superbugs Are Winning. India's New Antibiotic Discoveries Could Turn The Tide
The story in brief
India's pharma industry is making strides against antimicrobial resistance with Wockhardt's development of Zaynich, a novel antibiotic combination of cefepime and zidebactam, approved by the FDA for complicated urinary tract infections. The company also developed enmetazobactam to restore cefepime's effectiveness against resistant bacteria, marking a shift from affordable copies to original drug innovation.